Can-Fite BioPharma Ltd.

ILA 269.00As of Sun 8 Nov 2026, 12:00 UTC
TASE:CANFHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (57.32%)
Div yield —
ROE (211.37%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (91.03%)
Mkt cap ILS 16.31M
ROIC (132.55%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 309
14.95%
109.19%
Buy 8|2|6|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
4.54
4.88
4.71
4.90
21.96%
26.69%
15.92%
15.48%
Revenue$M
1.465
1.483
1.483
1.549
6.52%
5.68%
4.02%
2.88%
Peers (US$5.096M)
Cap (US$)
PE
4.606M
—
Capital
TTM
5Y
10Y
Leveragex
0.502
0.478
0.430
EBIT/Intx
0.158
0.233
0.281
Own earn%
6.41
33.80
28.35
Sh yield%
37.77
41.57
40.98
Owners
Insiders/Inst%
2.91
50.92
Short interest%
2.45
SBC / revenue%
4.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
20–24
$1 testx
—
Incr. ROIC%
−1